Skip to main content
Premium Trial:

Request an Annual Quote

Tekmira Prices Common Stock Offering

Premium

Tekmira Pharmaceuticals said this week that it has priced a public offering of 3.75 million shares of its common stock at $8 a share, for gross proceeds of $30 million.

Tekmira stock closed at $8.82 on Wednesday.

The company said that the underwriters of the offering have also been granted an option to purchase an additional 562,500 shares.

The offering is expected to close on or about Oct. 22.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.